Developing FuturaLead, the world’s first intrathecal spinal cord stimulation (iSCS) lead, placed directly on the spinal cord surface, enabling superior efficacy and closed-loop neuromodulation via ECAP sensing.
Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Pre-seed
MODALITY
SCS
FORM FACTOR
Implant
INTERFACE DEPTH
Minimally invasive
INDICATION
Pain/migraine
TARGET USER
Patients
REGULATORY STAGE
Preclinical
Spinally is differentiated by its intrathecal spinal cord stimulation lead, which sits directly on the cord surface and aims to improve efficacy while enabling ECAP-based closed-loop control. This is a technically bold hardware innovation in a market otherwise dominated by incremental lead improvements.
.svg)
